Image Credit: Canva (representational purpose only)
Mysterious Fog in the US , Canada and UK: A dense, eerie fog with a "burning chemical-like smell" has spooked a good part of North America and parts of the United Kingdom and Canada. With social media amplifying all concerns, this phenomenon has sparked attention across all social media platforms. However, at the heart of this mysterious fog are a conjunction of natural events, social psychology, and environmental conditions that culminated in all the conspiracy theories and public health fears. Here's a closer look at the mysterious fog, its potential causes, and the societal response it has triggered.
The first reports of this "mysterious fog" came in from Florida where a resident said that they experienced respiratory symptoms, feverish warmth, and stomach cramps after contact with the fog. Similar stories started flooding social media, and within a day or two, a sinister force seemed to sweep across the United States, Canada, and parts of the UK. From Texas to Minnesota, people reported weird odors and health issues that they thought were linked to this bizarre atmospheric event.
Some witnesses were said to see "white particles" swirling through the air; theories ranged from a chemical attack or experimental weapon to drone-related chemical dispersals and references to historical military experiments, such as the infamous 1950s "Operation Sea-Spray."
Fuel to the fire were added when videos and posts, hundreds of thousands in number, began circulating on social media sites like TikTok and X (formerly Twitter) speculating on the origin of the fog. Hashtags like #ToxicFog went trending for days. Hysteria created a self-reinforcing loop in which every post spurred further scrutiny and fear.
Fog is essentially a low-lying cloud formed when the air temperature cools to its dew point, causing water vapor to condense into tiny droplets or ice crystals. Several types of fog—advection fog, radiation fog, and valley fog—can form depending on conditions such as warm, moist air moving over cooler land or when temperatures plummet rapidly under clear skies.
Such chemical-like smell as reported during the occurrence of fog events is sometimes attributed to air pollution. It acts like a sponge, where it absorbs these pollutants, which include sulfur dioxide and nitrogen oxides, among others, that emit from industries. This mixture, therefore, leads to a stench that could be mistaken as unnatural or even toxic.
Also Read: Health Concerns Rise As US, Canada, and UK Come Under The Blanket Of Thick, Dense, Toxic Fog
High moisture levels from fog can significantly exacerbate symptoms related to respiration, but especially in already predisposed asthmatics and allergy patients. The connection of these symptoms with actual fever, stomach cramps, and puffy eyes is too remote. Experts assume that the irritating effects of entrapped pollutants trapped in fog tend to affect more the eyes and throat rather than the rest of the body affected by some report.
Social media amplified a natural weather event into a health epidemic. It made the personal experience of individuals become a cause for fear and speculation, a domino effect.
According to psychologists, this is a concept of selective perception, wherein once people's attention is drawn to environmental anomalies, they begin to notice them. This mirrors earlier panics, such as the Seattle windshield pitting panic of 1954. Then, atomic bomb testing caused fear in many and started to have people looking at their windshields for small marks that they had not seen before. Likewise, postings on the strangeness of the fog probably increased public awareness and suspicion, with people looking to attach unrelated symptoms to the phenomenon.
The fog hysteria shares a commonality with other instances of mass panic, such as the "drone sightings" of recent years or the Cold War-era fears of biological warfare.
Also Read: Mysterious Fog Is Making Americans Sick
These events underscore how fear can cloud judgment, especially when amplified by social media and sensationalist headlines. While historical cases, such as "Operation Sea-Spray," offer concrete evidence of the existence of unethical experiments, the jump from a natural weather condition to theories of chemical attacks exemplifies a more modern trend of connecting unrelated dots, all wonderfully seeded in distrust and anxiety.
Despite the swirling rumors, meteorologists and scientists are in agreement that the mysterious fog is not as alarming as it seems. It is well known that fog traps and amplifies pollutants, especially in urban and industrial regions. Moreover, winter months are the most conducive for fog formation, so its recent prevalence is unsurprising.
On the other hand, environmentalists advise that the fog should wake everyone up to increased levels of pollution. The reported odors and health irritations could be just symptoms of far deeper systemic issues like industrial emissions and lack of control over air quality.
The authorities must be transparent in their communication to combat misinformation and allay public fears. Governments and environmental agencies must provide timely updates on weather phenomena, air quality, and health risks. Initiatives like real-time pollutant tracking and public education campaigns can help demystify natural occurrences while addressing valid environmental concerns.
The mysterious Canada fog is a compelling case study in how environmental events intersect with psychology and societal dynamics. While rooted in natural phenomena, the fog became a vessel for collective fears, amplified by modern technology and historical anxieties.
In this information era where communication occurs at an almost lightning pace, the fog becomes a metaphor that reminds everyone about scientific literacy, environmental responsibility, and an effective balance when considering public concern. Whether perceived as a marvel of nature or as a tale that serves to teach, it left a very powerful mark in people's minds.
Credit: iStock
The Ebola outbreak continues to grow, with 2,344 confirmed cases and 930 deaths, according to the latest government update.
In its July 18 situation update, the Ministry of Health said response efforts have been strengthened across the five affected provinces: Haut-Uélé, Ituri, Nord-Kivu, Sud-Kivu, and Tshopo.
“To date, 2,344 confirmed cases have been recorded, including 724 patients in isolation or hospitalization, 466 people recovered, and 930 deaths,” the Ministry said.
The case fatality rate stands at 39.7%, while the contact tracing rate has reached 85.8%. Ituri remains the epicentre of the outbreak and continues to intensify response efforts.
Health teams are continuing surveillance, case management, and contact tracing to contain the spread of the disease.
According to the ministry, surveillance and contact tracing systems remain fully mobilised, with 83 new confirmed cases reported nationwide. Case management has also improved, with 22 new recoveries recorded in the past 24 hours. Sud-Kivu and Tshopo remain stable, with no new affected health zones.
Canada has temporarily denied entry to foreign nationals who have been in Congo within the previous 21 days as part of measures to reduce the risk of Ebola transmission.
"Limiting entry of foreign nationals who have been in (Congo) in the previous 21 days may reduce public health risks for Canadians," Canada's Public Health Agency said in a statement.
However, the World Health Organization (WHO) advises against travel or trade restrictions during Ebola outbreaks, warning that such measures can increase stigma and hamper outbreak control. The global health agency also continues to assess the risk of international spread from the Congo outbreak as low.
Last week, the United States also introduced measures requiring travellers who had been in Congo within the previous 21 days to enter the country only through designated airports. Seven American aid workers who had been working in Congo are currently quarantining in Kenya.
Authorities have recorded at least 12 attacks on health facilities and response teams since the outbreak began in mid-May, largely driven by misinformation and public skepticism. Many healthcare workers have also gone on strike over unpaid wages, AP News reported.
At least 36 health workers have died after becoming infected with Ebola. The WHO has also warned that 80% of new Ebola cases are emerging from unknown chains of transmission, indicating that the outbreak is spreading faster than health officials can trace infections.
Ebola is a severe and often fatal viral hemorrhagic fever first identified in 1976. Since then, more than 30 outbreaks have been recorded, primarily in Central and West Africa.
The Ebola outbreak, declared in eastern Congo on May 15, is the fastest-growing Ebola outbreak on record. The outbreak is caused by the Bundibugyo virus, a less common Ebola virus species for which there is no approved vaccine or treatment.
The Bundibugyo virus spreads through direct contact with the blood or bodily fluids of a person infected with, or who has died from, the disease.
It can also spread through contact with contaminated objects such as clothing, bedding, needles, and medical equipment, as well as through infected animals, including bats and non-human primates. Historically, Bundibugyo virus outbreaks have recorded fatality rates ranging from 25% to 50%.
Symptoms of Bundibugyo virus disease are similar to other forms of Ebola and include:
Credit: AI
A study suggests that Leqembi (lecanemab), one of the first amyloid-targeted treatments for Alzheimer's disease, may help people maintain their cognitive abilities for longer than previously thought.
Researchers reported at the Alzheimer's Association International Conference (AAIC) 2026 that more than 75% of patients with early Alzheimer's disease remained stable, while nearly 7% showed improvement after receiving Leqembi for an average period of 17 months.
The findings come from the LEADER study, an ongoing observational study that evaluates the effectiveness of Leqembi outside the controlled environment of clinical trials.
The analysis included people with early Alzheimer's disease, including those with mild cognitive impairment (MCI) due to Alzheimer's and mild Alzheimer's dementia.
According to researchers:
The study is based on how the drug performs in routine medical practice, offering insight into its real-world effectiveness.
The drug clears amyloid-beta plaques, one of the hallmarks of Alzheimer's disease. Researchers believe that reducing amyloids may control the progression of the disease when treatment begins early.
Commenting on the new findings, Dr. Michael Irizarry, Deputy Chief Clinical Officer and Senior Vice President at Eisai Inc., said: "These real-world data reinforce the meaningful impact that early diagnosis and treatment with LEQEMBI can have for people living with early Alzheimer's disease."
The company said the results provide encouraging evidence that the benefits observed in clinical trials are translating into everyday clinical practice.
Also read: WHO's New Dementia Guidelines Prioritize Healthy Habits, Warn Against Supplements
Despite the encouraging results, experts say that Leqembi is not appropriate for everyone with Alzheimer's disease. The treatment is suitable for people in the early stages of Alzheimer's disease with confirmed amyloid pathology.
Patients receiving Leqembi require regular monitoring because the drug can cause amyloid-related imaging abnormalities (ARIA), which may involve brain swelling or bleeding.
While many cases are asymptomatic, some can be serious, making MRI monitor an important part of treatment.
For years, amyloid plaques have been at the center of Alzheimer’s research. These protein clumps build up between neurons and are believed to interfere with communication and trigger inflammation, eventually killing brain cells.
While there’s still debate over whether amyloid is a cause or symptom of Alzheimer’s, clearing these plaques remains one of the leading therapeutic targets.
The latest real-world evidence presented at AAIC 2026 strengthens confidence in Leqembi as a treatment that may help slow the progression of early Alzheimer's disease.
While the therapy does not reverse the condition or cure dementia, keeping patients clinically stable for longer could translate into more time with preserved independence and daily functioning.
Credit: AI
Unlike many other cancers, cervical cancer is considered highly preventable through a combination of HPV vaccination, regular screening, and timely treatment of precancerous lesions.
India has recorded a significant decline in cervical cancer burden, with new cases falling by 37% over the past decade, according to data from the Indian Council of Medical Research's (ICMR) National Cancer Registry Programme (NCRP).
Experts say widespread screening, awareness, and increasing uptake of the human papillomavirus (HPV) vaccine have contributed to the milestone.
The latest estimates show that the number of new cervical cancer cases has dropped from approximately 1.27 lakh annually to around 79,000, marking a major public health milestone in the fight against one of the most common cancers affecting Indian women.
"Cervical cancer is one of the few cancers that can largely be prevented through timely screening and vaccination," Dr. Amitabh Shankar, Head of Preventive Oncology at Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, AIIMS, was quoted as saying.
He attributed the decline to improved awareness, wider availability of screening services, and the gradual expansion of HPV vaccination.
According to experts, early detection through routine cervical cancer screening allows precancerous changes to be identified and treated before they develop into cancer.
At the same time, HPV vaccination protects against high-risk strains of the human papillomavirus, the leading cause of cervical cancer.
The report suggests that increased access to healthcare services, government-led awareness initiatives, and preventive programs have played an important role in reducing the cases of cervical cancer.
Despite the progress, specialists caution that cervical cancer continues to be a major health concern in India, particularly in rural and underserved regions where screening coverage and HPV vaccination remain limited.
They emphasize that expanding HPV vaccination among eligible adolescents, strengthening population-based screening programs, and improving early diagnosis will be essential to prevent it.
The human papillomavirus causes more than 200 known infections. While some types lead to benign skin warts, others are responsible for severe health threats, such as cervical, throat, anal, and penile cancers.
The HPV vaccine provides strong protection against the most lethal strains, avoiding long-term health complications. It helps the immune system recognize and fight off high-risk strains of the virus before they cause harm. It protects against:
Cervix is located in the pelvic cavity, about 3 to 6 inches inside the vaginal canal. It serves as the entrance to the uterus to the vagina. As per the World Health Organization (WHO), almost all cervial cancer are linked to human papillomaviruses (HPV) which are transmitted through sexual contact
Cervical cancer has no symptoms in the early days and therefore, is hard to detect until it has spread. Early-stage cervical cancer symptoms include:
© 2024 Bennett, Coleman & Company Limited